Research Paper Volume 13, Issue 20 pp 23739—23756
Loganin substantially ameliorates molecular deficits, pathologies and cognitive impairment in a mouse model of Alzheimer’s disease
Figure 8. Schematic diagram demonstrating the proposed potential mechanisms involving in neuroprotective effects of loganin. Administration of loganin induced the change of hippocampal proteome and AD pathology. Obviously, the abnormal expression of the differentially expressed proteins may directly or indirectly regulate cognitive impairment of the 3xTg-AD mice.